| AAVS1 |
|
adeno-associated virus integration site 1
|
|
|
0.595 |
0.731 |
| ABO |
P16442
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase
|
Enzyme
|
|
0.427 |
0.885 |
| ACTN3 |
Q08043
|
actinin alpha 3 (gene/pseudogene)
|
|
|
0.663 |
0.500 |
| MMP12 |
P39900
|
matrix metallopeptidase 12
|
Enzyme
|
|
0.484 |
0.885 |
| COX2 |
P00403
|
cytochrome c oxidase subunit II
|
Enzyme
|
|
0.352 |
0.962 |
| CYTB |
P00156
|
cytochrome b
|
|
|
0.529 |
0.808 |
| ND1 |
P03886
|
NADH dehydrogenase, subunit 1 (complex I)
|
Enzyme
|
|
0.522 |
0.769 |
| NM |
|
neutrophil migration
|
|
|
0.473 |
0.808 |
| PECAM1 |
P16284
|
platelet and endothelial cell adhesion molecule 1
|
Cell adhesion
|
|
0.426 |
0.846 |
| ST2 |
|
suppression of tumorigenicity 2
|
|
|
0.576 |
0.692 |
| LAP |
|
Laryngeal adductor paralysis
|
|
|
0.619 |
0.731 |
| GHS |
|
Goldenhar syndrome
|
|
|
0.659 |
0.615 |
| NR2E3 |
Q9Y5X4
|
nuclear receptor subfamily 2 group E member 3
|
Nuclear receptor
|
|
0.603 |
0.500 |
| DIANPH |
|
diabetic nephropathy
|
|
|
0.678 |
0.500 |
| NANS |
Q9NR45
|
N-acetylneuraminate synthase
|
Enzyme
|
|
0.545 |
0.692 |
| MEG3 |
|
maternally expressed 3
|
|
|
0.471 |
0.846 |
| SPZ1 |
Q9BXG8
|
spermatogenic leucine zipper 1
|
|
|
0.507 |
0.769 |
| MRGPRX3 |
Q96LB0
|
MAS related GPR family member X3
|
G-protein coupled receptor
|
|
0.529 |
0.923 |
| MRGPRX4 |
Q96LA9
|
MAS related GPR family member X4
|
G-protein coupled receptor
|
|
0.531 |
0.923 |
| MRGPRX1 |
Q96LB2
|
MAS related GPR family member X1
|
G-protein coupled receptor
|
|
0.531 |
0.923 |
| COPD |
|
Pulmonary disease, chronic obstructive, severe early-onset
|
|
|
0.456 |
0.885 |
| KCP |
Q6ZWJ8
|
kielin cysteine rich BMP regulator
|
|
|
0.839 |
0.154 |
| MALAT1 |
|
metastasis associated lung adenocarcinoma transcript 1
|
|
|
0.435 |
0.846 |
| MIR126 |
|
microRNA 126
|
|
|
0.447 |
0.846 |
| MIR130B |
|
microRNA 130b
|
|
|
0.547 |
0.808 |